RGX — Regenx Tech Income Statement
0.000.00%
Last trade - 00:00
- CA$3.96m
- CA$8.50m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.17 | 2.5 | 4.61 | 3.91 | 5.52 |
Operating Profit | -2.17 | -2.5 | -4.61 | -3.91 | -5.52 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.39 | -2.82 | -4.37 | -2.26 | -5.4 |
Net Income After Taxes | -2.39 | -2.82 | -4.37 | -2.26 | -5.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.39 | -2.82 | -4.37 | -2.26 | -5.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.39 | -2.82 | -4.37 | -2.26 | -5.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.062 | -0.071 | -0.051 | -0.02 | -0.028 |